Track the 셀루메드 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 셀루메드 has logged 37 public disclosures. Market capitalisation: €83.9bn. The latest transaction was disclosed on 23 March 2026 (Other). Among the most active insiders: 인스코비. Every trade is accessible without an account.
37
Insider Decl.
n/a
Thresholds
n/a
20 ops.
Buy Volume
n/a
4 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,805 of 29,064 companies
19.3
score / 100
Value
24
Quality
15
FCF yld-4.9%
Earn yld-2.7%
EV/EBITDA·
ROE-14%
Gross mgn4.7%
Net mgn-1.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.